Maximising the antimicrobial and anti-inflammatory performance of next generation therapeutics for Chronic Rhinosinusitis
Maximising the antimicrobial and anti-inflammatory performance of next generation therapeutics for Chronic Rhinosinusitis
最大限度地提高下一代慢性鼻窦炎疗法的抗菌和抗炎性能
批准号：
nhmrc : GNT1164562
负责人：
金额：
$76.74万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2019
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2019-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic Rhinosinusitis (CRS) is one of the few ear nose and throat diseases with no absolute cure. An alarming 1.8 million Australians continue to suffer from this disease. Current therapies cannot always control the disease. In this study, we will develop a new drug that will be delivered topically and can disperse bacterial biofilms, and has inherent anti-infective and anti-inflammatory properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
